ADVERTISEMENT

survival benefit

Research in Review

Statin Therapy May Improve Survival in Patients with Metastatic SCLC

01/14/2016

JCP Editors

In a retrospective study published in PLoS ONE, researchers found a survival benefit associated with statin use in patients with small cell lung cancer (SCLC) that has spread to other regions of the body. SCLC,...

In a retrospective study published in PLoS ONE, researchers found a survival benefit associated with statin use in patients with small cell lung cancer (SCLC) that has spread to other regions of the body. SCLC,...

In a...

01/14/2016

Journal of Clinical Pathways

Cabozantinib Bests Everolimus for Treatment of Advanced Renal Cell Carcinoma

01/12/2016

JCP Editors

Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...

Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...

...

01/12/2016

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

Dermatology Week

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

See Full Calendar

Advertisement

Advertisement